- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-22-0139943

About Aumgene Biosciences Private Limited
Data last updated:
Aumgene Biosciences Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 26 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2004PTC044192. Its GSTIN is 24AAFCA0560K1ZX (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23.85 Lakh. It is led by directors Anand Kumar Daga and Jaikumar Bajaj.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 8201/5 & 6 Road No. 8 G I D C Sachin, Surat, Gujarat, India – 394230.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.06 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹12.07 Cr (net margin 26.2%) and EBITDA of ₹18.51 Cr (EBITDA margin 40.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
The company has about 56 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aumgene Biosciences. As per MCA filings, the company has open charges of ₹26.3 Cr and satisfied charges of ₹2.5 Cr on record. Court records list 10 cases involving the company, including 8 filed by the company and 2 filed against it; 1 case is pending.
Aumgene Biosciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0139943). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aumgene.com.
Company details
Recognitions & Rankings of Aumgene Biosciences
Contact details
Aumgene Biosciences Private Limited's registered office is in Surat, Gujarat. Its website is aumgene.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 8201/5 & 6 Road No. 8 G I D C Sachin, Surat, Gujarat, India – 394230
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Aumgene Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aumgene Biosciences operates one associated brand: Aumgene Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of contract research & manufacturing of enzymes, probiotics & agribiotech products | aumgene.com |
Business activity
The main business activity of Aumgene Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aumgene Biosciences Private Limited, buy the company report.
Financials of Aumgene Biosciences Private Limited
FY 2024 filings availableAumgene Biosciences Private Limited reported revenue of ₹46.06 Cr (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 37% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.51 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40.2% | ||||
| Net Profit Margin | 26.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aumgene Biosciences Private Limited, buy the company report.
Board of directors of Aumgene Biosciences Private Limited
Aumgene Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Kumar Daga | Director | 26 May 2004 | 22 Years 5 Months | Current |
| Jaikumar Bajaj | Director | 26 May 2004 | 22 Years 5 Months | Current |
Peer comparison
Aumgene Biosciences Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Biosciences, Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amster Microcell Private Limited | ₹55.81 Cr (FY 2025) | 50.0% | Kadi, Gujarat, India | |||
| Infinita Biotech Private Limited | ₹52.26 Cr (FY 2024) | 119.0% | Vadodara, Gujarat, India | |||
| Aumgene Biosciences Private Limitedthis company | ₹46.06 Cr (FY 2025) | ₹12.07 Cr | 26.2% | 37.0% | 56 | Surat, Gujarat, India |
| Biolaxi Enzymes Private Limited | ₹45.8 Cr (FY 2025) | -4.0% | Thane, Maharashtra, India | |||
| Hi Tech Biosciences India Private Limited | ₹41.75 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India |
To see the full peer comparison of Aumgene Biosciences Private Limited, buy the company report.
Auditor
Aumgene Biosciences Private Limited is audited by S.K. KABRA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.K. KABRA & CO. | FY 2023 | 104508W |
Shareholding
The shareholding of Aumgene Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aumgene Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2024 | 101013622 | Sidbi | ₹5.9 Cr | Open | |
| 09 Nov 2023 | 100809209 | Axis Bank Limited | ₹9.95 Cr | Open | |
| 20 Oct 2023 | 100808753 | Axis Bank Limited | ₹9.95 Cr | Open | |
| 19 Mar 2014 | 10486315 | Biotechnology Industry Research Assistance Council | ₹50 Lakh | Open | |
| 14 Dec 2007 | 10083191 | Others | ₹1.25 Cr | Satisfied |
To see the full charge records of Aumgene Biosciences Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Aumgene Biosciences Private Limited has 10 court cases on record: 8 filed by Aumgene Biosciences, 2 filed against it. 1 case is pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 2 | 1 |
Cases on record (4 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by Meteoric Exim Private Ltd. | Pending |
| District court, SURAT, Gujarat | Criminal complaint | Filed by the company against Maps Enzymes Ltd Com. and 3 others | Disposed |
| District court, SURAT, Gujarat | Court case (CR EN) | Filed by the company against Maps Enzymes Ltd Com. and 3 others | Disposed |
| District court, SURAT, Gujarat | Criminal complaint | Filed against the company by Government of Gujarat | Disposed |
To see the full case history of Aumgene Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Aumgene Biosciences Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 43 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 43)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Dynamic Chemicals | |||
| an individual supplier | |||
| an individual supplier | |||
| SM Industrial Stores |
To see the full MSME payment records of Aumgene Biosciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Aumgene Biosciences Private Limited has a workforce of 56 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Aumgene Biosciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCA0560K1ZX | Gujarat | Active | 01 Jul 2017 |
| 24AAFCA0560K2ZW | Gujarat | Active | 01 Mar 2018 |
To see the full GST registrations and return filing status of Aumgene Biosciences Private Limited, buy the company report.
Recent activity
Aumgene Biosciences Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Shrikumar Daga ceased to be Director on 10 Feb 2020.
5 earlier events are in the company report.
News
Frequently asked questions
Aumgene Biosciences is an active private limited company based in Surat, Gujarat, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 26 May 2004 (22+ years old) and is registered under CIN U24231GJ2004PTC044192.
Aumgene Biosciences has 2 current directors:
- Anand Kumar Daga - Director
- Jaikumar Bajaj - Director
The latest financial statements of Aumgene Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aumgene Biosciences is 24AAFCA0560K1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAFCA0560K2ZW (Gujarat).
The CIN (Corporate Identification Number) of Aumgene Biosciences is U24231GJ2004PTC044192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aumgene Biosciences has 10 court cases on record: 8 filed by the company and 2 filed against it. 1 is pending.
Aumgene Biosciences was incorporated on 26 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Aumgene Biosciences by revenue are Amster Microcell Private Limited, Infinita Biotech Private Limited, Biolaxi Enzymes Private Limited, Hi Tech Biosciences India Private Limited, all in the Chemicals industry (Biosciences, Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shrikumar Daga ceased to be Director on 10 Feb 2020. Anand Kumar Daga was appointed as Director on 26 May 2004. Jaikumar Bajaj was appointed as Director on 26 May 2004.
Yes, Aumgene Biosciences is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-22-0139943).
Aumgene Biosciences has 12 MSME Form 1 returns on record between 2019 and 2023, listing 141 overdue payments to 43 micro and small suppliers. The latest return was filed on 29 Aug 2023.
Aumgene Biosciences can be reached through the website aumgene.com. Its registered office is in Surat, Gujarat, India.